Skip to main content

Glass is Green

Submitted by AdmNC on Fri, 05/20/2022 - 11:05

Did you know that glass is the only form of packaging with infinite recycling potential? Described by Nature as ‘The hidden gem in a carbon-neutral future’ [1], glass is made from natural and abundant raw materials, sand, soda ash and limestone, and can be 100% recycled without any loss of quality or product integrity throughout the process.

SGD Pharma celebrates the United Nations International Year of Glass 2022

Cette année, SGD Pharma célèbre « l’Année Internationale du Verre» proclamée par l’ONU

Webpackaging - Neville and More introduces SGD Pharma’s latest addition to product portfolio

Source: Webpackaging - 10 May 2022

Innovation

Our Innovation approach

GET INFUSED BY SGD PHARMA

One of the keys to SGD Pharma’s leadership position in the glass industry has always been its drive to continually innovate. Working closely with customers and researching the latest technologies, SGD Pharma seeks specific challenges to address through the research or application of new technology solutions. In essence, SGD Pharma connects products, processes and services to provide a unique and integrated packaging solution to meet ever-changing customer needs. SGD Pharma works closely with customers to solve their packaging challenges. We also focus on developing new innovations for the overall glass market.

SGD Pharma watches the glass market and its trends, to anticipate new needs and find solutions to address them. Our innovation is brought to life by our cross-functional teams, including R&D, Sales, Marketing, quality, regulatory, environment, health and safety, and operations, working together. We ensure new innovations area both technically viable and meet the exceptional quality and regulatory requirements our customer demand.

SGD Pharma works to solve tomorrow’s challenges today.

 

 

A clear process and a set of tools 

 

SGD Pharma, successful in innovation

A PROVEN TRACK RECORD OF INNOVATIVE PRODUCT AND SERVICE

SGD Pharma has continuously dedicated significant resources to Research and Development. These continual R&D efforts have allowed us to become :

  • A pioneer in the implementation of clean rooms for inspection and packing in all its factories.
  • The first pharmaceutical packaging company to be certified ISO 15378 (ISO 9001 in addition to the GMPs – Good Manufacturing Practices).

SGD Pharma also has proven track records of product range extension:

  • U-Save® vial, a unique design
    • U-shaped bottle for a complete liquid delivery.
    • Provides 100% of product recovery for high value nasal spray drugs.
    • U-save® is used worldwide and approved for several nasal sprays (calcitonine…)
  • EasyLyo®, simply stronger vial
    • Specially designed injectable vials to comply with the specific requirements of the lyophilization process.
    • Reduce risk of breakage thanks to the optimized design.
    • A full range of products available from 5 ml to 100 ml successfully embraced by biotech and pharma labs.
  • Clareo:
    • Type II premium injection vial
    • Breakage rate reduction
    • Lower total cost of Ownership
  • Sterinity:
    • Type I Ready-to-Use & premium high quality sterile and depyrogenated molded glass vials
    • Flexibility & safety of supply
    • Faster to market
    • Lower total cost of Ownership

Internal siliconization treatment for glass packaging

Internal siliconization

SILICONIZATION
A SPECIAL TREATMENT ADDING VALUE TO YOUR PRODUCT

Siliconization is realized with an aqueous emulsion of a polydimethysiloxanic oil, conforming to all pharmacopeias, sprayed inside the vials. The silicone film is fixed onto glass through the annealing lehr. All vials from 5ml to 1L, clear or amber, Type I, II or III glass may be siliconized. To maintain the quality of the coating, siliconized vials should be stored in dry condition and at moderate temperature.
Silicone breaks down at temperature over 350° C.

Major qualities products for pharmaceutical

  • It provides a protective layer useful for fragile molecules, further minimizing the interactions between the product and the container

  • It prevents high viscosity infusions from sticking to the internal surface of the vials giving them a perfect transparency

  • Finally, due to its hydrophobic properties, the silicone coating ensures a higher restitution rate down to the last drop of product

  • Compatibility tests between the product formulation and the siliconized vials have to be performed. The resistance of the silicone coating depends on the chemical structure of the pharmaceutical product, as well as its dissolving power on silicone. 

For more details, please click here 

Type I molded glass vials

Your critical applications

We understand that the chemical stability of your therapeutic product is vital, which is why our Type I molded glass vials are carefully designed and manufactured with the highest integrity, ideally suited to a diverse range of application needs, including:

Blood and blood components

Plasma, platelets, red blood cells, white blood cells, immunoglobulins, albumin and more are highly valuable for treating numerous diseases and protecting health.

Discover more

Oncology

Drug stability and sterility are crucial for patient safety. The mechanical resistance of molded glass is particularly important to ensure the integrity of cytotoxic cancer therapies.

Discover more

Antibiotics

Flexibility, integrity, and cost are essential features of glass packaging for the antibiotic supply chain – all met by our extensive Type I molded glass range of vials and infusion bottles.

Discover more

Diagnostics

Diagnostic agents and contrast media are essential for diagnostic imaging. Molded glass vials are popular for parenteral contrast media due to chemical stability and inertness.

Discover more

Hospital solutions

Glass packaging offers many important benefits for Standard Solutions (sterilized water, saline, and glucose) and parenteral nutrition applications in hospitals.

Discover more

Animal health

Molded glass is the ideal solution for veterinary products such as injectable anti-infectives, given its practical and ergonomic design.

Discover more

Respiratory

Type I glass is a popular packaging option for respiratory therapies, notably for nasal drug products and parenteral vials, owing to its superior mechanical resistance.

Discover more

Quality Policy

Commitment & Accountabilities

SGD Pharma is committed to protecting and improving patient health by providing high quality, reliable and innovative products to our customers in the pharmaceutical industry.

Part of our mission is putting patient health as the top priority when we are making decisions.

All employees and external contributors work to meet SGD Pharma quality objectives. Each participant involved in the production of our glass vials, bottles and ampoules is held directly responsible for the quality of the product that is being made.

Put our customers at the heart of our priorities

Put our customers at the heart of our priorities

  • Ensure that each employee understands the needs of our customers and the pharmaceutical industry.
  • Be recognized by our customers for reliability in the quality of our products and service.
  • Provide fast and efficient technical support.

Incorporate the requirements of the pharmaceutical industry

Incorporate the requirements of the pharmaceutical industry

  • Maintain ISO 15378 certification at all our sites, according to the rules of Good Manufacturing Practices applicable to primary packaging in the pharmaceutical industry.
  • Verify the proper application of relevant regulations and standards at appropriate intervals.
  • Be vigilant with regard to regulatory changes related to bottles in the pharmaceutical industry through proactive monitoring.

Develop our skills

Develop our skills

  • Ensure that each employee is fully aware of SGD Pharma’s quality objectives and takes an active part in achieving the targets set.
  • Regularly evaluate employee skills and qualifications and plan the actions necessary to ensure that an adequate level is maintained.
  • Train each employee to build on their skills to achieve our required quality objectives.

Move towards zero defects

Move towards zero defects

  • Complete quality performance reviews at Group level and at each site to define an action plan, taking into account data analysis and the results of quality and customer service indicators.
  • Evaluate the risks of non-conformity by using adapted tools (change control, FMEA study), allowing the implementation of preventive actions.
  • Improve the robustness of our processes by systematically using problem-solving methods.
Subscribe to